Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | 13.9% | n/a |
ROCE | 26.2% |
Latest | F'cast | |
---|---|---|
P/E | 12.9 | n/a |
PEG | n/a | n/a |
Pr/Revenue | 1.4 | n/a |
Pr/Book | 1.6 |
Latest | F'cast | |
---|---|---|
Revenue | 14.0% | n/a |
PBT | n/a | n/a |
EPS | -28.4% | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-20 | 1,252.95 | 28.84 | 3.76¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-21 | 1,646.10 | 17.67 | 5.77¢ | 18.9 | 0.4 | +54% | n/a | 0.0% |
31-Dec-22 | 2,368.25 | 27.98 | 5.75¢ | 16.4 | n/a | -0% | n/a | 0.0% |
31-Dec-23 | 256.53 | (39.31) | 6.49p | 13.9 | 1.1 | +13% | n/a | 0.0% |
31-Dec-24 | 292.54 | 11.70 | 4.65p | 17.2 | n/a | -28% | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Director Declaration | 14-May-2025 | 15:00 | RNS |
Block listing Interim Review | 01-May-2025 | 12:00 | RNS |
Director/PDMR Shareholding | 16-Apr-2025 | 15:00 | RNS |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 60.00p |
Change Today | 1.00p |
% Change | 1.69 % |
52 Week High | 87.40 |
52 Week Low | 58.80 |
Volume | 467,112 |
Shares Issued | 690.48m |
Market Cap | £414.29m |
Beta | 0.02 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Latest | Previous | |
---|---|---|
Special | ||
Ex-Div | 26-Jun-25 | |
Paid | 03-Jul-25 | |
Amount | 3.00p |
Time | Volume / Share Price |
16:35 | 263,000 @ 60.00p |
16:35 | 20,222 @ 60.00p |
16:35 | 16,737 @ 60.00p |
16:35 | 29,660 @ 60.00p |
16:35 | 32,810 @ 60.00p |
Chair | Paul Manduca |
CEO | Martin Vohánka |
CFO | Oskar Zahn |
You are here: research